RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering

World News: . []

TEL-AVIV Israel and RALEIGH, NC Dec 06 2018 GLOBE NEWSWIRE -- NasdaqRDHL Tel-Aviv Stock ExchangeRDHL (“RedHill” or the Company a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointest inal di...

More news and information about RedHill Biopharma Ltd.

Published By:

Globe Newswire: 13:44 GMT Thursday 6th December 2018

Published: .

Search for other references to "redhill" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us